Back to search

Poland· PL-100477330

Comirnaty Original/Omicron BA.4-5

A covid-19, rna-based vaccine product containing szczepionka mrna przeciw covid-19 (ze zmodyfikowanymi nukleozydami), registered in Poland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedComirnaty Original/Omicron BA.4-5ATCJ07BN01REGISTER NO.PL-100477330PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)
Manufacturer
BioNTech Manufacturing GmbH
Country
Poland (PL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    04260703260408
  • gtin
    05909991503185
  • gtin
    05909991503192

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e5310d1e-0afe-4518-9dd3-6db7621eebaf
GET /v1/drugs/e5310d1e-0afe-4518-9dd3-6db7621eebaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat do sporządzania dyspersji do wstrzykiwań",
  "source": "urpl",
  "strength": "10 mcg (0,2 ml)/dawkę",
  "packaging": "04260703260408 ¦ Rp ¦ EU/1/20/1528/011 ¦ 147965\n10 fiol. 1,3 ml (10 dawek/fiol., 100 dawek)\nRp ¦ EU/1/20/1528/012 ¦ 147966\n195 fiol. 1,3 ml (10 dawek/fiol., 1950 dawek)\n05909991503185 ¦ Rp ¦ 147972\n2 fiol. 1,3 ml (20 dawek, 10 dawek/fiol.)\n05909991503192 ¦ Rp ¦ 147973\n10 fiol. 1,3 ml (100 dawek, 10 dawek/fiol.)",
  "substance": null,
  "common_name": "Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)",
  "pl_product_id": "100477330",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.